Extracellular Unveils Europe’s Largest Contract Pilot Facility for Cultivated Meat & Seafood
CDMO Extracellular announces it has opened what it claims is Europe’s largest contract pilot plant for cultivated meat and seafood in Bristol, the UK. The facility, established for food-grade operations, will provide essential scale-up and manufacturing services to assist cultivated meat companies in achieving their production goals and mitigating the expense and time associated with building new sites. According to Extracellular, its pilot plant currently has an operational capacity of 200 L and …
UK: Extracellular Launches Licence-Free Cell Banks to Support Cultivated Meat Research
UK CDMO Extracellular announces the launch of new low-cost cell banks — free from licensing or commercial restrictions — intended for early-stage cultivated meat companies and researchers. The cell banks offer high-quality cow, pig, and sheep primary cells isolated from fat, muscle, and bone marrow tissues. They were developed through a collaborative project with the British biotechnology company Multus. Backed by the Good Food Institute and New Harvest, the cell bank …
Extracellular Secures New Investment to Boost Biomanufacturing of Cultivated Meat
Extracellular, a contract development and manufacturing organization (CDMO) for the cultivated meat industry based in the UK, announces it has secured new funding from various investors, bringing its total of raised funds to over $1.9 million. The CDMO will use the capital to meet its goal as a global leader and development partner for biomanufacturing cultivated meat at scale. The company already operates 200L bioreactors at its research labs at Science Creates …
UK’s Extracellular: The Challenge of Upscaling Cultivated Meat
How does a cultivated meat startup scale from producing prototypes to developing commercially viable products? The emerging cultivated meat industry faces significant challenges in bringing cost-effective products to the market. Most manufacturing processes have been adapted for the biomedical sector, which produces much lower volumes of outputs than the food industry will need to bring products to market. Supported by Science Creates and based in Bristol, Extracellular was founded in 2022 by …